First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting

By sjmartinez • September 29, 2024

Nicholas SB, Correa-Rotter R, Desai NR, Guo L, Navaneethan SD, Pantalone KM, Wanner C, Hamacher S, Fatoba ST, Horvat-Broecker A, Garreta-Rufas A, Gay A, Merz M, Wheeler DC. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. J Nephrol. 2024 Sep 28. doi: 10.1007/s40620-024-02070-y. Epub ahead of print. PMID: 39340711.

Tags: Chronic kidney disease, Finerenone, Nephrology, Non-interventional study, Publications, Type 2 diabetes

A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide

Dao KT, Dhillon A, Uddin SS, Eppanapally S, Lai H. A Unique Case of a Mildly Symptomatic Patient With Severe Hypokalemia Secondary to Furosemide. J[...]

Semaglutide and kidney function: direct kidney protection or an artifact?

Ayoub I, Wong G, Glassock RJ. Semaglutide and kidney function: direct kidney protection or an artifact? Kidney Int. 2024 Nov 18:S0085-2538(24)00793-2. doi: 10.1016/j.kint.2024.11.003. Epub ahead[...]

Association of Fibroblast Growth Factor 23 and Cardiac Mechanics in the Cardiovascular Health Study

Jain K, Katz R, Isakova T, Kizer JR, Sharma S, Psaty BM, Shah S, Ix J, Mehta R. Association of Fibroblast Growth Factor 23 and[...]